FGF19 and Insulin resistance: The intracerebroventricular (ICV) effects of FGF19 in models of metabolic dysfunction have been studied in obese mice and rats [34,35], and it was observed that FGF19 acts on the hypothalamus, reducing food intake and body weight gain, and improving glucose tolerance and insulin resistance.